Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.49 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7910516 | 1.00 | CYP2C9 (0.54) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL9345177 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL10660536 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL9345185 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL9346164 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL10764754 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL11277229 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL10660532 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL9346177 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT | |
| SCHEMBL10764762 | 0.95 | CYP2C9 (0.50) | CYP2C9RAB9ALMNAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4733949-A | LOW TEMPERATURE RESPONSE TIME | HITACHI, LTD. (JP) | 1988-03-29 | — | — | US | claimed |
| EP-0033947-B2 | LIQUID CRYSTAL DISPLAY ELEMENT | KABUSHIKI KAISHA TOSHIBA (JP) | 1987-01-14 | — | — | EP | claimed |
| EP-0033947-B1 | LIQUID CRYSTAL DISPLAY ELEMENT | KABUSHIKI KAISHA TOSHIBA (JP) | 1983-09-21 | — | — | EP | claimed |
| EP-0033947-A2 | Liquid crystal display element | KABUSHIKI KAISHA TOSHIBA (JP) | 1981-08-19 | — | — | EP | claimed |
| US-12024665-B2 | Polymer-stabilized liquid crystal composition and use thereof | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) | 2024-07-02 | — | — | US | disclosed |
| US-20230287272-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | DIC CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-20230183572-A1 | LIQUID CRYSTAL COMPOSITION WITH GOOD FREQUENCY DEPENDENCE AND LIQUID CRYSTAL DISPLAY ELEMENT | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| EP-3347434-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-03-29 | — | — | EP | disclosed |
| CN-115373749-A | Method for identifying PCIE terminal equipment and computing equipment | 超聚变数字技术有限公司 | 2022-11-22 | — | — | CN | disclosed |
| US-20150337200-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT, AND LIQUID CRYSTAL DISPLAY | DIC CORPORATION (JP) | 2015-11-26 | — | — | US | disclosed |
| US-20150337200-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT, AND LIQUID CRYSTAL DISPLAY | DIC CORPORATION (JP) | 2015-11-26 | — | — | US | disclosed |
| EP-0030277-B1 | PARTIALLY HYDROGENATED OLIGO-1,4-PHENYLENES, DIELECTRICS CONTAINING THEM AND ELECTRO-OPTICAL INDICATING DEVICE | MERCK PATENT GmbH (DE) | 1983-07-27 | — | — | EP | disclosed |
| EP-0031021-B1 | TETRAHYDROQUINAZOLINES, PROCESS FOR THEIR PREPARATION, LIQUID CRYSTALLINE DIELECTRICS CONTAINING THEM AND ELECTRO-OPTICAL DISPLAY ELEMENT | MERCK PATENT GmbH (DE) | 1983-05-18 | — | — | EP | disclosed |
| EP-0069387-A2 | Liquid crystal display device | Hitachi, Ltd. (JP) | 1983-01-12 | — | — | EP | disclosed |
| US-4366080-A | Liquid crystal display element | TOKYO SHIBAURA DENKI KABUSHIKI KAISHA (JP) | 1982-12-28 | — | — | US | disclosed |
| US-4331552-A | Liquid crystalline, partially hydrogenated oligo-1,4-phenylenes and dielectrics and electro-optical display elements containing them | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1982-05-25 | — | — | US | disclosed |
| EP-0037902-A1 | Liquid crystal display element | KABUSHIKI KAISHA TOSHIBA (JP) | 1981-10-21 | — | — | EP | disclosed |
| EP-0033947-A2 | Liquid crystal display element | KABUSHIKI KAISHA TOSHIBA (JP) | 1981-08-19 | — | — | EP | disclosed |
| EP-0030277-A1 | Partially hydrogenated oligo-1,4-phenylenes, dielectrics containing them and electro-optical indicating device | MERCK PATENT GmbH (DE) | 1981-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | CYP2C9 3955/4885RAB9A 3577/4885LMNA 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.